Top Markets
#1 Islamic Coin Islamic Coin +155.95%
#2 Siren Siren +37.05%
#3 Venom Venom +20.55%
#4 Arowana Arowana +18.48%
#5 Cysic Cysic +16.20%
#6 Verus Coin Verus Coin +15.50%
#7 Perle Perle +13.44%
#8 KUB Coin KUB Coin +12.84%
#9 RedStone RedStone +12.47%
#10 OpenEden OpenEden +12.23%
Coin of the day
Islamic Coin Islamic Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Clasificación en acciones #31786
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Precio por acción
$0.21291741
Última sincronización: 2025-04-18
Capitalización bursátil
$12.07M
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
KR
Comercio PCL, Inc. (241820)

Categoría

Healthcare
Ratio P/S de PCL, Inc. (241820)
Ratio P/S al August 2026 TTM: 3.15
Según los informes financieros más recientes y el precio de las acciones de PCL, Inc., el ratio P/S actual (TTM) es 3.15. Al final de 2023, el ratio P/S era 18.24.
Historial del ratio P/S de PCL, Inc. desde 2015 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 3.15 -87.36%
2024 24.96 36.88%
2023 18.24 283.15%
2022 4.76 -45.57%
2021 8.74 19.24%
2020 7.33 -99.68%
2019 2.28K 207.15%
2018 742.49 119.01%
2017 339.03 117.88%
2016 155.60 -58.72%
2015 376.97 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 30.99%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 59.53%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -11.73%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 16.30%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.10 156.71%
US